Cyrevia Trademark Details
Word Mark | Cyrevia |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Accentia Biopharmaceuticals, Inc. of Tampa, FL
View all trademarks for Accentia Biopharmaceuticals, Inc.Serial Number | 85493632 |
---|---|
Status Date | Monday, February 17, 2014 |
Filing Date | Monday, February 17, 2014 |
Attorney | Corey K. Cho |
Correspondent
COREY K. CHO
SALIWANCHIK, LLOYD & EISENSCHENK
PO BOX 142950
GAINESVILLE, FL 32614-2950
SALIWANCHIK, LLOYD & EISENSCHENK
PO BOX 142950
GAINESVILLE, FL 32614-2950
Case File Statements
Goods & Services | Pharmaceutical preparation, comprising intravenously administered cyclophosphamide, a cytotoxic drug, for the purpose of rebooting the immune system in the treatment and prevention of immune disorders |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Tuesday, December 20, 2011 |
Primary Code | 005 |
Trademark Timeline
-
Dec 13 2011Trademark application filed with USPTO
-
Dec 16 2011New Application Entered In Tram
-
Dec 20 2011New Application Office Supplied Data Entered In Tram
-
Mar 22 2012Approved For Pub - Principal Register
-
Mar 22 2012Assigned To Examiner
-
May 02 2012Notification of Notice of Publication E-Mailed
-
May 22 2012Official Gazette Publication Confirmation E-Mailed
-
May 22 2012Published For Opposition
-
Jul 17 2012Noa E-Mailed - Sou Required From Applicant
-
Jan 17 2013Extension 1 Granted
-
Jan 17 2013Extension 1 Filed
-
Jan 17 2013Teas Extension Received
-
Jan 19 2013Notice of Approval of Extension Request E-Mailed
-
Jul 16 2013Extension 2 Filed
-
Jul 16 2013Teas Extension Received
-
Aug 09 2013Case Assigned To Intent To Use Paralegal
-
Aug 10 2013Extension 2 Granted
-
Aug 13 2013Notice of Approval of Extension Request E-Mailed
-
Feb 17 2014Abandonment - No Use Statement Filed
-
Feb 18 2014Abandonment Notice Mailed - No Use Statement Filed